Last updated on February 2018

Phase 1 Study of MM-398 Plus Cyclophosphamide in Pediatric Solid Tumors


Brief description of study

This is a Phase 1 study of the combination of two drugs: MM-398 and Cyclophosphamide. The goal is to find the highest dose of MM-398 that can be given safely when it is used together with the chemotherapy drug Cyclophosphamide.

Clinical Study Identifier: NCT02013336

Contact Investigators or Research Sites near you

Start Over

Susan Heavner

University Of Oklahoma Health Sciences Center
Oklahoma City, OK United States
  Connect »

Alison Patterson

UT Southwestern
Dallas, TX United States
  Connect »

Amanda Knight, RN, BSN, CCRP

Texas Tech University Health Sciences Center
Lubbock, TX United States
  Connect »

Adam Fiebelkorn

Midwest Children's Hospital
Milwaukee, WI United States
  Connect »